Synchronous Minimally Invasive Resection of Carcinomas of Lung and Esophagus After Downstaging by Palliative Immunotherapy

We report a case of an elderly patient with synchronous locally advanced bilateral lung and esophageal adenocarcinomas downstaged by atypical multimodality induction therapy. A short course of palliative immunotherapy (stopped for complications after 2 cycles), followed by stereotactic lung irradiation and later neoadjuvant fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy, allowed subsequent synchronous minimally invasive combined esophagectomy and anatomical lung resection with excellent outcome. This report further illustrates the technical feasibility of minimally invasive synchronous anatomical lung and esophagus resection after multimodal therapy, including immunotherapy.

Authors

Institutions

Publication Details

Journal
Annals of Thoracic Surgery Short Reports
Published
2025-02-26
DOI
https://doi.org/10.1016/j.atssr.2025.01.024
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synchronous Minimally Invasive Resection of Carcinomas of Lung and Esophagus After Downstaging by Palliative Immunotherapy

G. Anton Decker, Sven Philippi, Bob Edon, Robbe Van Dyck et al.
Annals of Thoracic Surgery Short Reports
Esophageal Cancer Research and Treatment
article

Synchronous Minimally Invasive Resection of Carcinomas of Lung and Esophagus After Downstaging by Palliative Immunotherapy

G. Anton Decker, Sven Philippi, Bob Edon, Robbe Van Dyck, Thierry Wagner, Flaviu Crisan
article en

Abstract

We report a case of an elderly patient with synchronous locally advanced bilateral lung and esophageal adenocarcinomas downstaged by atypical multimodality induction therapy. A short course of palliative immunotherapy (stopped for complications after 2 cycles), followed by stereotactic lung irradiation and later neoadjuvant fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy, allowed subsequent synchronous minimally invasive combined esophagectomy and anatomical lung resection with excellent outcome. This report further illustrates the technical feasibility of minimally invasive synchronous anatomical lung and esophagus resection after multimodal therapy, including immunotherapy.

Annals of Thoracic Surgery Short ReportsVol. 3(3)
Luxembourg School of Business (LU), Luxembourg Institute of Health (LU), Centre François Baclesse (LU), Laboratoire National de Santé (LU)
Zero hunger
Openalex Percentile: Top 94%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.